CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Deep vein thrombosis - prevention for travellers - Management
Additional information
- If low molecular weight heparin (LMWH) is prescribed:
- Ensure that appropriate arrangements are in place for LMWH administration (for example, that a nurse is available) or that the person is given training if the drug will be self-administered.
- If LMWH is indicated, it should be administered before departure.
- The British Medical Association warns that cabin crew are generally not trained in the administration of drugs by injection, and therefore the passenger or an accompanying person must be able to do this when necessary [BMA, 2004].
- Prescribe sufficient LMWH to cover the outgoing and any subsequent connecting or return flights.
- Prescribe LMWH as pre-filled syringes for ease of administration.
- Provide the person with a letter that explains why they have to carry needles and syringes while travelling, to show to security, immigration, and customs officials.
- Warn about the increased risk of bleeding and bruising.
- Advise the person to seek urgent medical advice if there is uncontrolled or excessive bleeding or bruising, or if they have a sudden severe headache (possible intracranial haemorrhage), or gastrointestinal pains (signifying possible gastrointestinal bleeding).
- Give advice on the safe storage and disposal of needles and syringes ('sharps').
© NHS Institute for Innovation and Improvement